Preventing allograft rejection with antibodies to adhesion...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2120500

2120500 9306864 PCTABS00021 Compositions and methods for prolonging the function of a transplanted allograft and preventing transplant rejection are provided. Particularly, tolerance is induced in a recipient mammal to a transplanted organ or tissue by treatment with a composition comprising more than one adhesion molecule inhibitor including antibodies to the adhesion molecule and corresponding ligand, e.g. antibodies to LFA-1 and ICAM-1. Compositions of the invention find additional use in treating inflammatory reactions, as well as allergies and autoimmune diseases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Preventing allograft rejection with antibodies to adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preventing allograft rejection with antibodies to adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventing allograft rejection with antibodies to adhesion... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1391372

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.